MetaADEDB 2.0 @ LMMD
halobetasol
(BDSYKGHYMJNPAB-LICBFIPMSA-N)
Structure
SMILES
CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F)C(=O)CCl
Molecular Formula:
C25H31ClF2O5
Molecular Weight:
484.960
Log P:
4.0511
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
80.67
CAS Number(s):
66852-54-8
Synonym(s)
1.
halobetasol
2.
6 alpha-fluoroclobetasol 17-propionate
3.
6-fluoroclobetasol 17-propionate
4.
CGP 14 458
5.
CGP 14458
6.
CGP-14458
7.
Ultravate
8.
halobetasol propionate
9.
ulobetasol
External Link(s)
MeSHC064466
PubChem Compound6918178
ChEBI135782
CHEMBLCHEMBL1200908
DrugCentral1349
KEGGdr:D04409
ZINC3920028
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 9OFFSIDES
US FAERS
2Application site painFAERS: 3OFFSIDES
US FAERS
3ErythemaFAERS: 3OFFSIDES
US FAERS
4PruritusFAERS: 3US FAERS
5Application site warmthFAERS: 2OFFSIDES
US FAERS
6Burning sensationFAERS: 2OFFSIDES
US FAERS
7Drug ineffective for unapproved indicationFAERS: 2US FAERS
8Incorrect drug administration durationFAERS: 2US FAERS
9Product use issueFAERS: 2US FAERS
10AcneFAERS: 1US FAERS
11Drug exposure during pregnancyFAERS: 1US FAERS
12Drug prescribing errorFAERS: 1US FAERS
13Dry skinFAERS: 1US FAERS
14EczemaFAERS: 1OFFSIDES
US FAERS
15Expired product administeredFAERS: 1US FAERS
16FatigueFAERS: 1US FAERS
17Feeling ColdFAERS: 1US FAERS
18Incorrect dose administeredFAERS: 1US FAERS
19InfertilityFAERS: 1US FAERS
20Pharmaceutical product complaintFAERS: 1OFFSIDES
US FAERS
21Post procedural complicationFAERS: 1US FAERS
22Product administered at inappropriate siteFAERS: 1US FAERS
23Product package associated injuryFAERS: 1US FAERS
24Product use in unapproved indicationFAERS: 1US FAERS
25PsoriasisFAERS: 1OFFSIDES
US FAERS
26Pustular psoriasisFAERS: 1US FAERS
27Reaction to excipientFAERS: 1US FAERS
28Rebound effectFAERS: 1US FAERS
29Skin lesionFAERS: 1OFFSIDES
US FAERS
30Temperature regulation disorderFAERS: 1US FAERS
31Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
32Abdominal discomfortOFFSIDES
33Actinic keratosisOFFSIDES
34Acute respiratory failureOFFSIDES
35Acute sinusitisOFFSIDES
36AdenocarcinomaOFFSIDES
37AnhedoniaOFFSIDES
38AnxietyOFFSIDES
39ArteriosclerosisOFFSIDES
40ArthropathyOFFSIDES
41AstheniaOFFSIDES
42AsthmaOFFSIDES
43AtherosclerosisOFFSIDES
44Blood glucose decreasedOFFSIDES
45CD4 Lymphocytes DecreasedOFFSIDES
46CataractOFFSIDES
47CellulitisOFFSIDES
48Chest PainOFFSIDES
49Chronic Obstructive Airway DiseaseOFFSIDES
50Circumstance or information capable of leading to medication errorOFFSIDES
51Congenital tricuspid valve incompetenceOFFSIDES
52CyanosisOFFSIDES
53DemyelinationOFFSIDES
54DiabetesOFFSIDES
55DizzinessOFFSIDES
56DrowsinessOFFSIDES
57Drug toxicityOFFSIDES
58Drug withdrawal headacheOFFSIDES
59Economic problemOFFSIDES
60Erythema NodosumOFFSIDES
61Eye InfectionOFFSIDES
62FormicationOFFSIDES
63Hypoaesthesia facialOFFSIDES
64ImmunosuppressionOFFSIDES
65Joint sprainOFFSIDES
66Latent TuberculosisOFFSIDES
67Limb injuryOFFSIDES
68Limb operationOFFSIDES
69Lung hyperinflationOFFSIDES
70Mycosis FungoidesOFFSIDES
71NasopharyngitisOFFSIDES
72Oropharyngeal blisteringOFFSIDES
73OsteomyelitisOFFSIDES
74PCO2 decreasedOFFSIDES
75PainOFFSIDES
76Procedural hypertensionOFFSIDES
77Pulmonary HypertensionOFFSIDES
78Quality of life decreasedOFFSIDES
79Reaction to medical agent preservativesOFFSIDES
80Rheumatic Heart DiseaseOFFSIDES
81RhinitisOFFSIDES
82TinnitusOFFSIDES
83Unevaluable eventOFFSIDES
84Vaginal mycosisOFFSIDES
85Ventricular FibrillationOFFSIDES
86Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.